Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oramed Pharmaceuticals (ORMP) Asset Utilization Ratio (2022 - 2025)

Oramed Pharmaceuticals' Asset Utilization Ratio history spans 4 years, with the latest figure at 0.01 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio changed N/A year-over-year to 0.01; the TTM value through Dec 2025 reached 0.01, changed N/A, while the annual FY2023 figure was 0.01, N/A changed from the prior year.
  • Asset Utilization Ratio reached 0.01 in Q4 2025 per ORMP's latest filing, down from 0.01 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q2 2023 to a low of 0.0 in Q3 2024.
  • Average Asset Utilization Ratio over 4 years is 0.01, with a median of 0.01 recorded in 2025.
  • Peak YoY movement for Asset Utilization Ratio: plummeted 142.14% in 2024, then soared 1798.05% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.02 in 2022, then plummeted by 66.92% to 0.01 in 2023, then tumbled by 182.27% to 0.0 in 2024, then soared by 281.45% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Asset Utilization Ratio are 0.01 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025).